Mitochondrial and metabolic remodelling in human skin fibroblasts in response to glucose availability

FEBS J. 2022 Sep;289(17):5198-5217. doi: 10.1111/febs.16413. Epub 2022 Mar 7.

Abstract

Cell culture conditions highly influence cell metabolism in vitro. This is relevant for preclinical assays, for which fibroblasts are an interesting cell model, with applications in regenerative medicine, diagnostics and therapeutic development for personalized medicine, and the validation of ingredients for cosmetics. Given these cells' short lifespan in culture, we aimed to identify the best cell culture conditions and promising markers to study mitochondrial health and stress in normal human dermal fibroblasts (NHDF). We tested the effect of reducing glucose concentration in the cell medium from high glucose (HGm) to a more physiological level [low glucose medium (LGm)], or its complete removal and replacement by galactose [medium that forces oxidative phosphorylation (OXPHOSm)], always in the presence of glutamine and pyruvate. We have demonstrated that only with OXPHOSm was it possible to observe the selective inhibition of mitochondrial adenosine triphosphate (ATP) production. This reliance on mitochondrial ATP was accompanied by changes in oxygen consumption rate and extracellular acidification rate, oxidation of citric acid cycle substrates, fatty acids, lactate, and other substrates, increased mitochondrial network extension and polarization, the increased protein content of voltage-dependent anion channel (VDAC) and peroxisome proliferator-activated receptor gamma coactivator 1-alpha and changes in several key transcripts related to energy metabolism. LGm did not promote significant metabolic changes in NHDF, although mitochondrial network extension and VDAC protein content were increased compared to HGm-cultured cells. Our results indicate that short-term adaptation to OXPHOSm is ideal for studying mitochondrial health and stress in NHDF.

Keywords: bioenergetics; human fibroblasts; metabolic remodelling; metabolism; mitochondrial health.

Publication types

  • Research Support, Non-U.S. Gov't

MeSH terms

  • Adenosine Triphosphate / metabolism
  • Energy Metabolism / physiology
  • Fibroblasts / metabolism
  • Glucose* / metabolism
  • Glucose* / pharmacology
  • Humans
  • Mitochondria* / metabolism
  • Oxidative Phosphorylation

Substances

  • Adenosine Triphosphate
  • Glucose

Associated data

  • RefSeq/NM_001101
  • RefSeq/NM_001002027
  • RefSeq/NC_012920
  • RefSeq/NM_004048
  • RefSeq/NM_001861
  • RefSeq/NM_019095
  • RefSeq/NM_018947
  • RefSeq/NM_001931
  • RefSeq/NM_000108
  • RefSeq/NM_002040
  • RefSeq/NM_005254
  • RefSeq/NM_000403.3
  • RefSeq/NM_000154.1
  • RefSeq/NM_002044.3
  • RefSeq/NM_000155.4
  • RefSeq/NM_002046.7
  • RefSeq/NM_014905.4
  • RefSeq/NM_013267.4
  • RefSeq/NM_006516
  • RefSeq/NM_000194
  • RefSeq/NM_005002
  • RefSeq/NM_005011
  • RefSeq/NM_000284
  • RefSeq/NM_001278549
  • RefSeq/NM_013261
  • RefSeq/NM_182470
  • RefSeq/NR_003286
  • RefSeq/AF479321
  • RefSeq/NM_004168
  • RefSeq/NM_000636
  • RefSeq/NM_003201
  • RefSeq/NM_00
  • RefSeq/3366
  • RefSeq/NM_003406